JP5066448B2 - 口内炎の予防または治療のための組成物および方法 - Google Patents

口内炎の予防または治療のための組成物および方法 Download PDF

Info

Publication number
JP5066448B2
JP5066448B2 JP2007530409A JP2007530409A JP5066448B2 JP 5066448 B2 JP5066448 B2 JP 5066448B2 JP 2007530409 A JP2007530409 A JP 2007530409A JP 2007530409 A JP2007530409 A JP 2007530409A JP 5066448 B2 JP5066448 B2 JP 5066448B2
Authority
JP
Japan
Prior art keywords
glutathione
acceptable salt
pharmacologically acceptable
stomatitis
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2007530409A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512381A5 (enExample
JP2008512381A (ja
Inventor
令 古川
健次郎 島田
ジョーンズ，ディーン
ジーグラー，トーマス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Hakko Bio Co Ltd
Original Assignee
Kyowa Hakko Bio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Bio Co Ltd filed Critical Kyowa Hakko Bio Co Ltd
Publication of JP2008512381A publication Critical patent/JP2008512381A/ja
Publication of JP2008512381A5 publication Critical patent/JP2008512381A5/ja
Application granted granted Critical
Publication of JP5066448B2 publication Critical patent/JP5066448B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
JP2007530409A 2004-09-03 2005-09-02 口内炎の予防または治療のための組成物および方法 Expired - Lifetime JP5066448B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60705304P 2004-09-03 2004-09-03
US60/607,053 2004-09-03
PCT/US2005/031364 WO2006028991A2 (en) 2004-09-03 2005-09-02 Composition and method for prevention or treatment of stomatits

Publications (3)

Publication Number Publication Date
JP2008512381A JP2008512381A (ja) 2008-04-24
JP2008512381A5 JP2008512381A5 (enExample) 2008-09-11
JP5066448B2 true JP5066448B2 (ja) 2012-11-07

Family

ID=36036881

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007530409A Expired - Lifetime JP5066448B2 (ja) 2004-09-03 2005-09-02 口内炎の予防または治療のための組成物および方法

Country Status (7)

Country Link
US (1) US8067537B2 (enExample)
EP (1) EP1789068B1 (enExample)
JP (1) JP5066448B2 (enExample)
CN (1) CN101027078B (enExample)
AT (1) ATE516040T1 (enExample)
CA (1) CA2578748C (enExample)
WO (1) WO2006028991A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018012157A1 (ja) 2016-07-14 2018-01-18 昭和電工株式会社 メラニン産生抑制剤、美白剤、線維芽細胞活性化剤、コラーゲン及び／又はエラスチン産生促進剤、及びシワ改善剤

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5408882B2 (ja) * 2008-01-23 2014-02-05 ヤマサ醤油株式会社 唾液分泌促進剤
EP2990048B1 (en) * 2013-01-21 2023-03-01 Kyowa Hakko Bio Co., Ltd. Nitric oxide concentration elevating agent
JP6582983B2 (ja) * 2013-07-31 2019-10-02 味の素株式会社 癌化学療法時の副作用軽減剤
DK3006045T3 (en) 2014-10-07 2017-07-17 Cyprumed Gmbh Pharmaceutical formulations for oral administration of peptide or protein drugs
US20160367620A1 (en) 2015-06-19 2016-12-22 Harry B. Demopoulos Glutathione
EP3359181A1 (en) 2015-10-07 2018-08-15 Cyprumed GmbH Pharmaceutical formulations for the oral delivery of peptide drugs
EP3622957A4 (en) * 2017-05-12 2021-01-27 Furukawa Research Office Co., Ltd. IMPROVING THE DEGREE OF ARTERIAL SATURATION WITH OXYGEN
JP7874258B2 (ja) * 2020-03-31 2026-06-16 株式会社古川リサーチオフィス 亜鉛化合物配合組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2250553A (en) * 1938-04-18 1941-07-29 Simon L Ruskin Medicinal preparation
DE3011437A1 (de) * 1980-03-25 1981-10-01 Hrvoje Dr. Zagreb Krnjevic Pharmazeutisches mittel zur heilung von entzuendlichen und/oder degenerativen und/oder atrophischen schleimhauterkrankungen
US4508898A (en) * 1980-09-16 1985-04-02 Ogilvie Kelvin K Antiviral triazine compounds
US4975434A (en) * 1986-05-27 1990-12-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antiviral and anticancer cyclopentenyl cytosine
US5204114A (en) 1992-03-30 1993-04-20 Health Maintenance Programs, Inc. Methods of manufacturing high dosage glutathione the tablets and capsules produced thereby
US5686436A (en) * 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
GB9620504D0 (en) * 1996-10-02 1996-11-20 Boehringer Ingelheim Ltd Compositions
WO1998029101A1 (en) 1996-12-31 1998-07-09 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
US6896899B2 (en) * 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
EP1402892A4 (en) 2001-06-11 2006-11-08 Kyowa Hakko Kogyo Kk Antiinflammatoric and antitussive compositions
JP2005530738A (ja) * 2002-04-16 2005-10-13 アイシス・イノヴェイション・リミテッド 組織障害の予防及び／又は治療のためのクルクミン
JP2003321356A (ja) * 2002-05-01 2003-11-11 Rohto Pharmaceut Co Ltd 催乳作用を有する組成物
US7625928B2 (en) * 2002-10-01 2009-12-01 Mitos Pharmaceuticals, Inc. Nitroxide radioprotector formulations and methods of use
JP4731321B2 (ja) 2003-07-22 2011-07-20 協和発酵バイオ株式会社 ウィルス感染症の予防または治療用組成物

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018012157A1 (ja) 2016-07-14 2018-01-18 昭和電工株式会社 メラニン産生抑制剤、美白剤、線維芽細胞活性化剤、コラーゲン及び／又はエラスチン産生促進剤、及びシワ改善剤
US10646487B2 (en) 2016-07-14 2020-05-12 Showa Denko K.K. Melanin production inhibitor, whitening agent, fibroblast activator, collagen and/or elastin production promotor and wrinkle ameliorant
US11045471B2 (en) 2016-07-14 2021-06-29 Showa Denko K.K. Melanin production inhibitor, whitening agent, fibroblast activator, collagen and/or elastin production promotor and wrinkle ameliorant

Also Published As

Publication number Publication date
WO2006028991A3 (en) 2006-04-27
HK1099918A1 (en) 2007-08-31
EP1789068A4 (en) 2007-10-17
CN101027078B (zh) 2012-07-04
JP2008512381A (ja) 2008-04-24
US20070259024A1 (en) 2007-11-08
US8067537B2 (en) 2011-11-29
CA2578748C (en) 2014-10-14
EP1789068A2 (en) 2007-05-30
EP1789068B1 (en) 2011-07-13
WO2006028991A2 (en) 2006-03-16
CA2578748A1 (en) 2006-03-16
CN101027078A (zh) 2007-08-29
ATE516040T1 (de) 2011-07-15

Similar Documents

Publication Publication Date Title
JP5921664B2 (ja) 皮膚の乾燥予防または改善用経口剤
JP4847756B2 (ja) ヒトβディフェンシン分泌促進剤
CN1816538B (zh) 病毒感染症的预防或者治疗用组合物
WO2014112641A1 (ja) 一酸化窒素濃度上昇剤
JP2008512381A (ja) 口内炎の予防または治療のための組成物および方法
WO2004039368A1 (ja) アトピー性皮膚炎の予防または治療用経口剤
US20060035957A1 (en) Preventive or remedy for bedsore
JP5885784B2 (ja) 経口組成物
JP2007161642A (ja) アルコール性肝障害抑制剤
JPWO2012157290A1 (ja) 非アルコール性脂肪性肝炎の予防改善剤
EP1795191A1 (en) Oral pharmaceutical for dry skin prevention or remedy
JP4347041B2 (ja) 消炎、鎮咳組成物
JP7162917B2 (ja) 心拍数低下剤
JP2004522698A (ja) 医薬組成物のための香料系およびそのような組成物の製造方法
JPH069419A (ja) マツエキスの嗜好性改善方法およびこの方法により得られる経口摂取物
HK1099918B (en) Composition and use for prevention or treatment of stomatitis
EP4349344A1 (en) Composition for improving or preventing iron deficiency anaemia
JP7300446B2 (ja) 外分泌促進剤
JP6329317B1 (ja) 血圧降下用組成物
JP2016130252A (ja) 歯周病予防および／または改善用食品用組成物及び経口投与剤
JP2021095358A (ja) Ａｇｒ２発現促進剤
WO2004085389A1 (ja) 脂質代謝改善剤
JP2005104852A (ja) モービリウィルス感染症の予防または治療用組成物
JPWO2003086378A1 (ja) 大腸炎および大腸がんの予防または治療用組成物
HK1102071A (en) Oral pharmaceutical for dry skin prevention or remedy

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080724

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080724

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20081017

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20090218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110517

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110810

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110906

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111206

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120524

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20120703

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120724

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120813

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5066448

Country of ref document: JP

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150817

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term